Colony-stimulating factors. A panel discussion.
One of the most exciting recent developments in cancer-related research has been the discovery and understanding of colony-stimulating factors. There is now a general optimism that these factors will be used in the treatment of a variety of solid tumors, lymphomas, and leukemias, as well as in the treatment of patients who are immunocompromised or undergoing bone marrow transplantation. We have gathered a distinguished panel of experts to discuss the current status of this rapidly moving field.
McGuire
W L
WL
University of Texas Health Science Center, San Antonio 78284.
Gabrilove
J
J
Moore
M A
MA
Rinehart
J
J
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D000818:Animals; D000970:Antineoplastic Agents; D001424:Bacterial Infections / Q000188:drug therapy; D003115:Colony-Stimulating Factors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D005544:Forecasting; D006801:Humans; D007108:Immune Tolerance; D009503:Neutropenia / Q000188:drug therapy; D013234:Stem Cells / Q000187:drug effects*; D014180:Transplantation
D000970:Antineoplastic Agents; D003115:Colony-Stimulating Factors